- Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique
-
Banakhar M, Hassouna M
- KMID: 2365719
- Int Neurourol J.
- 2016 Sep;20(3):250-254.
- doi: 10.5213/inj.1630498.249
PURPOSE: InterStim device is an U.S. Food and Drug Administration approved minimal invasive therapy for sacral neuromodulation for lower urinary tract dysfunction. Before InterStim implantation, a trial with the appropriate... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy
-
Gahzi AA, Banakhar M, Elterman D, Hassouna M
- KMID: 2400896
- Int Neurourol J.
- 2017 Dec;21(4):289-294.
- doi: 10.5213/inj.1734942.471
PURPOSE: Sacral neuromodulation (SNM) therapy is indicated for some refractory urological conditions. The electrode lead position in sacral x-rays during routine follow-up may predict the outcome of SNM therapy. To... -
- CITED
-
- Close
- SHARE
-
- Close
